Abstract |
The high molecular weight melanoma-associated antigen ( HMW-MAA) is a membrane-bound chondroitin sulphate proteoglycan that is highly expressed on the surface of melanoma cells. It represents an attractive target for immunotherapy of malignant melanoma. Previously, it was reported that HMW-MAA was detected in about 20-30% of primary acral lentiginous melanoma (ALM) lesions by immunohistochemical staining (IHC) of frozen sections with monoclonal antibodies (mAbs). In the present study, we examined the expression of HMW-MAA in 95 paraffin-embedded, primary ALM lesions and 13 primary superficial spreading melanoma (SSM) lesions. A total of 51 primary ALM lesions (53.6%) were positive for HMW-MAA. Almost all of these positive cases showed a weak staining intensity. On the other hand, all 13 primary SSM lesions were strongly positive for HMW-MAA expression. Our data showed that the staining intensity of HMW-MAA ALM lesions was weaker than that of SSM. Furthermore, the percentage of HMW-MAA positive staining in ALM lesions was higher than previously reported.
|
Authors | Hazuki Nishi, Yuji Inoue, Toshiro Kageshita, Minoru Takata, Hironobu Ihn |
Journal | Bioscience trends
(Biosci Trends)
Vol. 4
Issue 2
Pg. 86-9
(Apr 2010)
ISSN: 1881-7823 [Electronic] Japan |
PMID | 20448346
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Antigens, Neoplasm
- HMW-MAA
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
- Antigens, Neoplasm
(metabolism)
- Female
- Humans
- Immunohistochemistry
- Male
- Melanoma
(metabolism)
- Middle Aged
- Skin Neoplasms
(metabolism)
|